Among the four members of the EGFR family, ErbB2 (also called Neu and Her2) is also overexpressed in 20–30% of breast tumors, while the coexpression analysis did not find a significant positive or negative correlation between EGFR and ErbB2 overexpression (89–91). Here, ERBB2 is linked to breast neoplasm.